News and Events NovaBiotics provides a positive clinical data update for its breakthrough toenail health product, Tinexyl® PRO May 8, 2025 NovaBiotics & Liverpool School of Tropical Medicine Collaborate on Cysteamine Bitartrate as a Potential New Intervention in Mycobacterial Disease. Mar 24, 2025 The Institute of Podiatrists announce endorsement of Tinexyl PRO Jan 28, 2025 NovaBiotics Pharma Division Highlighted in Healthcare UK report Nov 20, 2024 NovaBiotics announces move to ONE BioHub Nov 5, 2024 NovaBiotics Consumer Health Signs Global Sales and Distribution Agreement for its Breakthrough Nail Health Solution, Tinexyl®. Oct 8, 2024 TinexylPRO Launched at Key Industry Events May 27, 2024 Appointment of Dr Trevor Phillips to the Board of NovaBiotics Sep 6, 2023 Publication of NovaBiotics’ peer reviewed research on cysteamine’s antiviral and anti-inflammatory mechanisms Aug 16, 2023 Additional International Organization for Standardisation (ISO) accreditations for NovaBiotics Jan 23, 2023 « Older Entries Categories Press Releases Events In the news Archives 2021 2020
NovaBiotics provides a positive clinical data update for its breakthrough toenail health product, Tinexyl® PRO May 8, 2025
NovaBiotics & Liverpool School of Tropical Medicine Collaborate on Cysteamine Bitartrate as a Potential New Intervention in Mycobacterial Disease. Mar 24, 2025
NovaBiotics Consumer Health Signs Global Sales and Distribution Agreement for its Breakthrough Nail Health Solution, Tinexyl®. Oct 8, 2024
Publication of NovaBiotics’ peer reviewed research on cysteamine’s antiviral and anti-inflammatory mechanisms Aug 16, 2023
Additional International Organization for Standardisation (ISO) accreditations for NovaBiotics Jan 23, 2023
